| 756488 |
FRONTIERS IN ONCOLOGY |
ADORA2A-AS1 Restricts Hepatocellular Carcinoma Progression via Binding HuR and Repressing FSCN1/AKT Axis |
2021-10-18 |
10.3389/fonc.2021.754835 |
Pu Jian, Zhang Ya, Wang Anmin, Qin Zebang, Zhuo Chenyi, Li Wenchuan, Xu Zuoming, Tang Qianli, Wang Jianchu, Wei Huamei |
| 756487 |
FRONTIERS IN ONCOLOGY |
Recurrence Beyond the Milan Criteria of HBV-Related Single Hepatocellular Carcinoma of 2–3 cm: Comparison of Resection and Ablation |
2021-10-18 |
10.3389/fonc.2021.757149 |
Chen Shuanggang, Ma Weimei, Shen Lujun, Wu Ying, Qi Han, Cao Fei, Huang Tao, Fan Weijun |
| 756486 |
FRONTIERS IN ONCOLOGY |
ARV-825 Demonstrates Antitumor Activity in Gastric Cancer via MYC-Targets and G2M-Checkpoint Signaling Pathways |
2021-10-18 |
10.3389/fonc.2021.753119 |
Liao Xinmei, Qian Xiaoqing, Zhang Zimu, Tao Yanfang, Li Zhiheng, Zhang Qian, Liang Hui, Li Xiaolu, Xie Yi, Zhuo Ran, Chen Yanling, Jiang You, Cao Haibo, Niu Jiaqi, Xue Cuili, Ni Jian, Pan Jian, Cui Daxiang |
| 756485 |
FRONTIERS IN ONCOLOGY |
MRI-Based Machine Learning in Differentiation Between Benign and Malignant Breast Lesions |
2021-10-18 |
10.3389/fonc.2021.552634 |
Zhao Yanjie, Chen Rong, Zhang Ting, Chen Chaoyue, Muhelisa Muhetaer, Huang Jingting, Xu Yan, Ma Xuelei |
| 756484 |
FRONTIERS IN ONCOLOGY |
Clinical and Preclinical Outcomes of Combining Targeted Therapy With Radiotherapy |
2021-10-18 |
10.3389/fonc.2021.749496 |
Elbanna May, Chowdhury Nayela N., Rhome Ryan, Fishel Melissa L. |
| 756483 |
FRONTIERS IN ONCOLOGY |
Recombinant Human Adenovirus-p53 Therapy for the Treatment of Cervical Cancer: A Meta-Analysis |
2021-10-18 |
10.3389/fonc.2021.748681 |
Guo Yaru, Chen Jiuzhou, Zhang Xiwen, Fang Miao, Xu Mingna, Zhang Longzhen, Rao Enyu, Xin Yong |
| 756482 |
FRONTIERS IN ONCOLOGY |
The Impact of Diabetes on the Prognosis of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: A Systematic Review and Meta-Analysis |
2021-10-18 |
10.3389/fonc.2021.741145 |
Gao Xiaoshuai, Zhou Liang, Ai Jianzhong, Wang Wei, Di Xingpeng, Peng Liao, Liao Banghua, Jin Xi, Li Hong, Wang Kunjie |
| 756481 |
FRONTIERS IN ONCOLOGY |
Corrigendum: Machine Learning-Based Analysis of Magnetic Resonance Radiomics for the Classification of Gliosarcoma and Glioblastoma |
2021-10-18 |
10.3389/fonc.2021.774369 |
Qian Zenghui, Zhang Lingling, Hu Jie, Chen Shuguang, Chen Hongyan, Shen Huicong, Zheng Fei, Zang Yuying, Chen Xuzhu |
| 756480 |
FRONTIERS IN ONCOLOGY |
Gut Microbiota for Esophageal Cancer: Role in Carcinogenesis and Clinical Implications |
2021-10-18 |
10.3389/fonc.2021.717242 |
Zhou Jianfeng, Sun Shangwei, Luan Siyuan, Xiao Xin, Yang Yushang, Mao Chengyi, Chen Longqi, Zeng Xiaoxi, Zhang Yonggang, Yuan Yong |
| 756479 |
FRONTIERS IN ONCOLOGY |
Prognostic Value of CEA, CA19-9, CA125, CA724, and CA242 in Serum and Ascites in Pseudomyxoma Peritonei |
2021-10-18 |
10.3389/fonc.2021.594763 |
Liang Lei, Fang Jingyang, Han Xuedi, Zhai Xichao, Song Yan, Lu Yiyan, Zhang Qian, Ma Ruiqing |
